78
Views
17
CrossRef citations to date
0
Altmetric
Case Report

Synergistic effect of regenerating agent plus cord blood serum eye drops for the treatment of resistant neurotrophic keratitis: a case report and a hypothesis for pathophysiologic mechanism

, , &
Pages 277-281 | Published online: 02 Nov 2015

References

  • SacchettiMLambiaseADiagnosis and management of neurotrophic keratitisClin Ophthalmol2014857157924672223
  • MüllerLJMarfurtCFKruseFTervoTMCorneal nerves: structure, contents and functionExp Eye Res20037652154212697417
  • PucaAMeglioMVariRTamburriniGTancrediAEvaluation of fifth nerve dysfunction in 136 patients with middle and posterior cranial fossaeEur Neurol19953533377737244
  • HyndiukRAKazarianELSchultzROSeidemanSNeurotrophic corneal ulcers in diabetes mellitusArch Ophthalmol19779521932196588113
  • MackieIANeuroparalytic keratitisFrauenfelderFRoyFHMeyerSMCurrent Ocular TherapyPhiladelphia, PAWB Saunders1995
  • JengBHDuppsWJJrAutologous serum 50% eye drops in the treatment of persistent corneal epithelial defectsCornea2009281104110819730088
  • GeremiccaWFonteCVecchioSBlood components for topical use in tissue regeneration: evaluation of corneal lesions treated with platelet lysate and considerations on repair mechanismsBlood Transfus2010810711220383304
  • YoonKCYouICImSKJeongTSParkYGChoiJApplication of umbilical cord serum eyedrops for the treatment of neurotrophic keratitisOphthalmology20071141637164217382396
  • Dompé SpAEvaluation of efficacy of 20 µg/ml rhNGF new formulation (with anti-oxidant) in patients with stage 2 and 3 neurotrophic keratitis Available from: http://clinicaltrials.gov/show/NCT02227147. NLM identifier: NCT02227147Accessed September 28, 2014
  • Dompé S.p.AEvaluation of safety and efficacy of rhNGF in patients with stage 2 and 3 neurotrophic keratitis. (REPARO) Available from: http://clinicaltrials.gov/show/NCT01756456. NLM identifier: NCT01756456Accessed September 28, 2014
  • Laboratoires TheaEfficacy and safety assessment of T4020 versus vehicule in patients with chronic neurotrophic keratitis or corneal ulcer Available from: http://clinicaltrials.gov/ct2/show/NCT01794312. NLM identifier: NCT01794312Accessed September 28, 2014
  • VersuraPProfazioVBuzziMEfficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eyeCornea20133241241822955120
  • YoonKCHeoHImSKYouICKimYHParkYGComparison of autologous serum and umbilical cord serum eye drops for dry eye syndromeAm J Ophthalmol2007144869217493572
  • RouetVHamma-KourbaliYPetitEA synthetic glycosaminoglycan mimetic bind vascular endothelial growth factor and modulates angiogenesisJ Biol Chem2005280327923280016014624
  • AlexakisCMestriesPGarciaSStructurally different RGTAs modulate collagen-type expression by cultured aortic smooth muscle cells via different pathways involving fibroblast growth factor-2 or transforming growth factor-β1FASEB J2004181147114915132978